NO20085212L - Nye pyridinanaloger - Google Patents
Nye pyridinanalogerInfo
- Publication number
- NO20085212L NO20085212L NO20085212A NO20085212A NO20085212L NO 20085212 L NO20085212 L NO 20085212L NO 20085212 A NO20085212 A NO 20085212A NO 20085212 A NO20085212 A NO 20085212A NO 20085212 L NO20085212 L NO 20085212L
- Authority
- NO
- Norway
- Prior art keywords
- pyridine analogs
- new pyridine
- formula
- analogs
- new
- Prior art date
Links
- 150000003222 pyridines Chemical class 0.000 title abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 239000002172 P2Y12 inhibitor Substances 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229960004676 antithrombotic agent Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0601466 | 2006-07-04 | ||
| PCT/SE2007/000642 WO2008004942A1 (en) | 2006-07-04 | 2007-07-02 | New pyridine analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20085212L true NO20085212L (no) | 2009-01-12 |
Family
ID=38894821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20085212A NO20085212L (no) | 2006-07-04 | 2008-12-15 | Nye pyridinanaloger |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20110059981A9 (de) |
| EP (1) | EP2041115A4 (de) |
| JP (1) | JP2009542642A (de) |
| KR (1) | KR20090036573A (de) |
| CN (1) | CN101511815A (de) |
| AU (1) | AU2007270082A1 (de) |
| BR (1) | BRPI0713957A2 (de) |
| CA (1) | CA2655629A1 (de) |
| IL (1) | IL195980A0 (de) |
| MX (1) | MX2008016557A (de) |
| NO (1) | NO20085212L (de) |
| WO (1) | WO2008004942A1 (de) |
| ZA (1) | ZA200810646B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007008237A (es) * | 2005-01-06 | 2007-08-17 | Astrazeneca Ab | Compuestos de piridina novedosos. |
| AU2006267148A1 (en) * | 2005-07-13 | 2007-01-18 | Astrazeneca Ab | New pyridine analogues |
| TW200815426A (en) * | 2006-06-28 | 2008-04-01 | Astrazeneca Ab | New pyridine analogues II 333 |
| TW200811133A (en) * | 2006-07-04 | 2008-03-01 | Astrazeneca Ab | New pyridine analogues III 334 |
| US20110059981A9 (en) * | 2006-07-04 | 2011-03-10 | Astrazeneca Ab | New Pyridine Analogues V |
| CN101511792A (zh) * | 2006-07-04 | 2009-08-19 | 阿斯利康(瑞典)有限公司 | 新的吡啶类似物 |
| BRPI0713401A2 (pt) * | 2006-07-04 | 2012-04-17 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação plaquetária |
| US20080200448A1 (en) * | 2007-01-12 | 2008-08-21 | Astrazeneca Ab | New Pyridine Analogues VIII 518 |
| BRPI0806529A2 (pt) * | 2007-01-12 | 2014-04-22 | Astrazeneca Ab | Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação de plaqueta |
| UY30867A1 (es) * | 2007-01-12 | 2008-09-02 | Astrazeneca Ab | Nuevos analogos de piridina vii 543 |
| US20090018166A1 (en) * | 2007-07-13 | 2009-01-15 | Astrazeneca Ab | New Pyridine Analogues X 161 |
| AR074628A1 (es) * | 2008-07-07 | 2011-02-02 | Astrazeneca Ab | Derivados de piridina 2- amino-6-alquil sustituidos utiles como inhibidores de p2y12 308 |
| US9539246B2 (en) | 2011-08-30 | 2017-01-10 | University Of Utah Research Foundation | Methods and compositions for treating nephrogenic diabetes insipidus |
| WO2018213377A1 (en) | 2017-05-17 | 2018-11-22 | Arcus Biosciences, Inc. | Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders |
| EP3762368B1 (de) | 2018-03-08 | 2022-01-26 | Incyte Corporation | Aminopyrazindiolverbindungen als pi3k-y-hemmer |
| US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6156758A (en) * | 1999-09-08 | 2000-12-05 | Isis Pharmaceuticals, Inc. | Antibacterial quinazoline compounds |
| DE60114994T2 (de) * | 2000-02-04 | 2006-08-03 | Portola Pharmaceuticals, Inc., South San Francisco | Blutplättchen-adp-rezeptor-inhibitoren |
| US6906063B2 (en) * | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
| US7018985B1 (en) * | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
| US7132408B2 (en) * | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| FR2820057A1 (fr) * | 2001-01-30 | 2002-08-02 | Ct De Transfert De Technologie | Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane |
| US7294635B2 (en) * | 2003-10-03 | 2007-11-13 | Portola Pharmaceuticals, Inc. | Substituted isoquinolinones |
| US7749981B2 (en) * | 2003-10-21 | 2010-07-06 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound |
| US7504497B2 (en) * | 2003-10-21 | 2009-03-17 | Inspire Pharmaceuticals, Inc. | Orally bioavailable compounds and methods for inhibiting platelet aggregation |
| US7335648B2 (en) * | 2003-10-21 | 2008-02-26 | Inspire Pharmaceuticals, Inc. | Non-nucleotide composition and method for inhibiting platelet aggregation |
| US8071624B2 (en) * | 2004-06-24 | 2011-12-06 | Incyte Corporation | N-substituted piperidines and their use as pharmaceuticals |
| MX2007008237A (es) * | 2005-01-06 | 2007-08-17 | Astrazeneca Ab | Compuestos de piridina novedosos. |
| BRPI0713401A2 (pt) * | 2006-07-04 | 2012-04-17 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação plaquetária |
| CN101511792A (zh) * | 2006-07-04 | 2009-08-19 | 阿斯利康(瑞典)有限公司 | 新的吡啶类似物 |
| US20110059981A9 (en) * | 2006-07-04 | 2011-03-10 | Astrazeneca Ab | New Pyridine Analogues V |
| TW200817375A (en) * | 2006-07-21 | 2008-04-16 | Irm Llc | Compounds and compositions as ITPKB inhibitors |
-
2007
- 2007-07-02 US US12/307,279 patent/US20110059981A9/en not_active Abandoned
- 2007-07-02 AU AU2007270082A patent/AU2007270082A1/en not_active Abandoned
- 2007-07-02 BR BRPI0713957-8A patent/BRPI0713957A2/pt not_active Application Discontinuation
- 2007-07-02 EP EP07748301A patent/EP2041115A4/de not_active Withdrawn
- 2007-07-02 WO PCT/SE2007/000642 patent/WO2008004942A1/en active Application Filing
- 2007-07-02 US US11/772,264 patent/US20080032992A1/en not_active Abandoned
- 2007-07-02 CN CNA2007800326292A patent/CN101511815A/zh active Pending
- 2007-07-02 MX MX2008016557A patent/MX2008016557A/es not_active Application Discontinuation
- 2007-07-02 CA CA002655629A patent/CA2655629A1/en not_active Abandoned
- 2007-07-02 JP JP2009518049A patent/JP2009542642A/ja active Pending
- 2007-07-02 KR KR1020097002251A patent/KR20090036573A/ko not_active Application Discontinuation
-
2008
- 2008-12-15 NO NO20085212A patent/NO20085212L/no not_active Application Discontinuation
- 2008-12-16 IL IL195980A patent/IL195980A0/en unknown
- 2008-12-17 ZA ZA200810646A patent/ZA200810646B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2041115A1 (de) | 2009-04-01 |
| KR20090036573A (ko) | 2009-04-14 |
| EP2041115A4 (de) | 2010-07-07 |
| MX2008016557A (es) | 2009-02-06 |
| BRPI0713957A2 (pt) | 2013-04-02 |
| IL195980A0 (en) | 2009-09-01 |
| ZA200810646B (en) | 2010-05-26 |
| CN101511815A (zh) | 2009-08-19 |
| CA2655629A1 (en) | 2008-01-10 |
| US20110059981A9 (en) | 2011-03-10 |
| US20080032992A1 (en) | 2008-02-07 |
| US20090318464A1 (en) | 2009-12-24 |
| WO2008004942A1 (en) | 2008-01-10 |
| AU2007270082A1 (en) | 2008-01-10 |
| JP2009542642A (ja) | 2009-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20085212L (no) | Nye pyridinanaloger | |
| NO20085218L (no) | Nye pyridinanaloger | |
| NO20085214L (no) | Nye pyridinanaloger | |
| NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
| NO20076682L (no) | Nye pyridinanaloger | |
| NO20090628L (no) | Pyridizinon derivativater | |
| NO20073101L (no) | Nye pyridinforbindelser | |
| NO20085213L (no) | Nye pyridinanaloger | |
| NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
| NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
| NO20092723L (no) | Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| NO20090835L (no) | Nye HIV-reverstranskriptaseinhibitorer | |
| NO20076059L (no) | 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer | |
| NO20083919L (no) | Pyridin- og pyrimidinderivater som mGluR2-antagonister | |
| NO20074258L (no) | Pyridin-2-karboksamidderivater som MGLUR5 antagonister | |
| NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer | |
| EA201001683A1 (ru) | Производные фенил- или пиридинилзамещенных индазолов | |
| NO20092412L (no) | Hydantoinderivater anvendes som MMP-inhibitorer | |
| NO20071504L (no) | Pyrimidinderivanter. | |
| NO20072963L (no) | 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere | |
| NO20084186L (no) | Nye aminer | |
| NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
| NO20076448L (no) | Novel piperidine carboxylic acid amide derivatives | |
| NO20083738L (no) | Sekundaere aminer som renininhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |